Quick Answer
Xenetic Biosciences, Inc. reported Net Income of -$2.68 million for fiscal year 2025.
Xenetic Biosciences, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$2.68M | +32.3% |
| 2024 | -$3.96M | +4.2% |
| 2023 | -$4.13M | +36.9% |
| 2022 | -$6.55M | -16.1% |
| 2021 | -$5.65M | +48.2% |
| 2020 | -$10.89M | +14.7% |
| 2019 | -$12.78M | -75.0% |
| 2018 | -$7.30M | -103.1% |
| 2017 | -$3.60M | +93.4% |
| 2016 | -$54.21M | -333.4% |
| 2015 | -$12.51M | +12.6% |
| 2014 | -$14.31M | -66.8% |
| 2013 | -$8.58M | -9521.0% |
| 2013 | -$89.2K | +0.0% |
| 2012 | -$89.2K | +31.2% |
| 2011 | -$129.7K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$509.9K | -16.8% | +26.0% |
| June 30, 2025 | -$688.7K | +45.9% | +23.7% |
| March 31, 2025 | -$903.1K | +24.4% | -106.8% |
| September 30, 2024 | -$436.7K | +58.6% | +65.7% |
| June 30, 2024 | -$1.27M | -21.2% | -6.6% |
| March 31, 2024 | -$1.20M | -39.5% | -13.2% |
| September 30, 2023 | -$1.06M | -31.3% | -0.4% |
| June 30, 2023 | -$1.05M | +60.7% | -22.7% |
- Xenetic Biosciences, Inc. showed an increase of +32.3% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, Xenetic Biosciences, Inc.’s net income has declined by 1967.4% (from -$129.7 thousand to -$2.68 million).
- The most recent figure is from Xenetic Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: